FDA Inspection
Glaukos CorporationGlaukos Corporation – FDA Inspection, Apr 22, 2025
Record Details
This FDA Inspection record concerns Glaukos Corporation, with an inspection on April 22, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 1b4713bf-a869-4279-8c47-8e76dc9f26ea
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1267669
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Glaukos Corporation
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 15, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 19, 2023 | Not classified | Los Angeles District Office | |
| August 3, 2018 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| June 10, 2016 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| June 11, 2013 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Glaukos Corporation
- FDA Inspection 1251714 - 2024-08-15
- FDA Inspection 1211136 - 2023-07-19
- FDA Inspection 1068254 - 2018-08-03
- FDA Inspection 981961 - 2016-06-10
- FDA Inspection 835427 - 2013-06-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.